Jennifer Carter - Profile and Investment Details

Investor Profile

Jennifer Carter is a Venture Capital, Investor based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as Javelin Oncology, N-of-One, Inc., The Blue Venture Fund, CareMax, Inc. (NASDAQ: CMAX), DFP Healthcare Acquisitions Corp (Nasdaq MKT: DFPHU), Jumo Health, eCaring, Yale University —Smilow Cancer Hospital, Q-State Biosciences, Inc., Target Cancer Foundation, Transparency Life Sciences, JLC Precision Health Strategies, LLC, Xsphera Biosciences Inc, OncoCyte Corp(NYSE MKT: OCX), HouseWorks LLC. Over time, Jennifer Carter has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jennifer Carter is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Hospitals, Wellness, Immunotherapy, Rare Diseases, Healthcare Innovation, Health Technology, Artificial Intelligence (AI), Technology, Biotechnology, Drug Development, Specialty Pharma, Electronic Health Records (EHR), Health and Hospital Services, Precision Medicine, Clinical Trials, Specialty Pharmacy, Gene Therapy, Consulting, Personalized Medicine, Health Diagnostics, Digital Health, Medical, B2B, Health Tech, Molecular Diagnostics, Healthcare Technology, Oncology may find it worthwhile to explore potential connections with Jennifer Carter, as their portfolio suggests a familiarity and interest in this area.

Understanding Jennifer Carter’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.